Protective effect of Ginkgo biloba extract on cytotoxicity induced by aflatoxin B1 in HepG2 cells

Yan-rong HAO,Fang YANG,Ji CAO,Chao OU,Jing-jing ZHANG,Xiao-xian DUAN,Chun YANG,Yuan LI,Jian-jia SU
DOI: https://doi.org/10.3969/j.issn.1673-5269.2008.23.010
2008-01-01
Abstract:Objective: To study the cellular and molecular mechanisms by which the antioxidants of Ginkgo biloba extract (EGb761) inhibit AFB1-induced toxic changes in human hepatocytes (HepG2 cells). Methods: HepG2 cells were subjected to various concentrations of AFB1 in culture medium. The inhibitory rate of cell growth was measured by MTT assay. The cell survival effects of EGb761 was determined by using MTT and FCM on the cells exposed to AFB1. Finally, the products of oxidative reaction such as the reactive oxygen species (ROS) and malondialdehyde (MDA) in the HepG2 cells were measured by dichlorodihydrofluorescein diacetate (DCFH-DA) and thibabituric acid (TBA) assays. Results: AFB1 exhibited significant cytotoxicity to HepG2 cells, IC50 was 15 μg/mL. At different time (24, 48 and 72 hours), EGb761 (219 μg/ mL) could effectively inhibite the decreases of the cells viability (28%, 47% and 47%) and the enhancement of intracellular ROS level and MDA formation induced by AFB1 (15 μg/mL), P < 0.01. Conclusion: HepG2 cells pre-treated with EGb761 are protected from the toxic effects of AFB1 at both the cellular and molecular levels which the possible underlying mechanism is its antioxidation.
What problem does this paper attempt to address?